Is Biomerica Inc (BMRA) undervalued? · rev $5.3M
Biomerica Inc (BMRA) is a medical devices company listed on US.
This page asks whether Biomerica Inc (BMRA) looks cheap on cached numbers — not a DCF toy and not a buy alert.
Latest reported BMRA revenue for 2025-05-31 was $5.3M. Net income was -$5.0M. Revenue was down 1.9% from 2024-05-31 to 2025-05-31. BMRA currently screens at market cap $8.0M.
BMRA currently screens at market cap $8.0M. Cheap versus history or peers still needs a filing reason; a low multiple can be a value trap.
A new BMRA 10-Q can flip this screen overnight. The SEC page is the source.
Not investment advice. Compare BMRA to the stock page model before you treat a low multiple as a gift.
Not investment advice.